Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 704 of 1,261
  1. US 9283256

    Antibacterial composition comprising Salvia extracts

    Botanic Century (Beijing) Co. Ltd. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  2. US 9283300

    Use of midkine protein and the protein-containing medical device

    GENERAL REGENERATIVES, LTD. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  3. US 9283185

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  4. US 9283220

    Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith

    IMUNEKS FARMA ILAC SANAYI VE TICARET ANONIM SIRKETI PAK IS MERKEZI · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  5. US 9284546

    Human cystathionine beta-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  6. US 9284380

    Anti-ErbB3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  7. US 9284543

    Neutral active soluble truncated PH20 polypeptides and uses thereof

    HALOZYME, INC. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  8. US 9284411

    Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds

    Serina Therapeutics, Inc. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  9. US 9284367

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  10. US 9284276

    N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  11. US 9284251

    Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions

    OBSCHESTVOS S OGRANITCHENNOI OTVETSTVENNOSTJU “OXYGON” · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  12. US 9283233

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  13. US 9283238

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  14. US 9283194

    Methods for protease assisted protein delivery

    The Regents of the University of California · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  15. US 9278096

    Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity

    Takeda Pharmaceuticals North America, Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  16. US 9279366

    Steam powered engine

    SPINDYNE LLC · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  17. US 9279019

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  18. US 9279009

    FILIP1L nucleic acid fragments

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  19. US 9278942

    Non-steroidal compounds as androgen receptor modulators

    FLX Discoveries Oy · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  20. US 9278931

    Cyclopropaneamine compound

    Takeda Pharmaceutical Company Limited · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  21. US 9278161

    Tissue-separating fatty acid adhesion barrier

    ATRIUM MEDICAL CORPORATION · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  22. US 9278923

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  23. US 9278921

    Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

    QUANTUM GENOMICS · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  24. US 9278125

    Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

    Sanaria Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.